Research Article

Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer

Figure 5

Differential PTK6 expression in various clinicopathological parameters, including (a) age, (b) T stage, (c) M stage, (d) N stage, (e) pathologic stage, (f) histological type, (g) PR status, (h) ER status, and (i) HER2 status. , , and .
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)